Sandra R. Ding

New York Oncology Hematology

Papers

1

Total Citations

19

H-Index

1

About

Dr. Sandra R. Ding is a pioneering gynecologic oncologist and robotic surgeon whose work focuses on fertility-preserving treatments for cervical cancer. Her most cited study, a 2012 case report, introduced a groundbreaking approach for stage IB2 cervical cancer: combining neoadjuvant chemotherapy with simultaneous robotic radical trachelectomy and tubal sterilization reversal. This innovative procedure demonstrated that even advanced-stage patients could retain reproductive potential without compromising oncologic outcomes, challenging traditional radical hysterectomy protocols. With 19 citations, this work has influenced surgical oncology guidelines and inspired further research into multimodal fertility-sparing strategies. Dr. Ding’s contributions bridge the gap between aggressive cancer treatment and reproductive medicine, offering hope to young women facing cervical cancer. Her expertise in robotic surgery and neoadjuvant protocols positions her as a leader in minimally invasive, patient-centered oncology. By prioritizing both survival and quality of life, Dr. Ding has reshaped clinical approaches to cervical cancer, making her a vital figure in the evolution of gynecologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
19
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Neoadjuvant Chemotherapy Followed by Simultaneous Robotic Radical Trachelectomy and Reversal of Tubal Sterilization in Stage IB2 Cervical Cancer
19 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: New York Oncology Hematology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago